Rational design of small molecules as vaccine adjuvants
2014; American Association for the Advancement of Science; Volume: 6; Issue: 263 Linguagem: Inglês
10.1126/scitranslmed.3009980
ISSN1946-6242
AutoresTom Wu, Manmohan Singh, Andrew T. Miller, Ennio De Gregorio, Francesco Doro, Ugo D’Oro, David Skibinski, M. Lamine Mbow, Simone Bufali, Ann Herman, Alex Cortez, Yongkai Li, Bishnu P. Nayak, Elaine Tritto, Christophe Filippi, Gillis R. Otten, Luis A. Brito, Elisabetta Monaci, Chun Li, Susanna Aprea, Sara Valentini, Samuele Calabrό, Donatello Laera, Brunella Brunelli, Elena Caproni, Padma Malyala, Rekha G. Panchal, Travis K. Warren, Sina Bavari, Derek T. O’Hagan, M. Cooke, Nicholas M. Valiante,
Tópico(s)Monoclonal and Polyclonal Antibodies Research
ResumoSmall-molecule immune potentiators can be engineered to be potent adjuvants with localized innate immune activation and short in vivo residence times.
Referência(s)